Gadoteric acid - Sanochemia PharmazeutikaAlternative Names: Cyclolux
Latest Information Update: 12 Oct 2015
At a glance
- Originator Sanochemia Pharmazeutika
- Class Gadolinium-containing contrast agents; Heterocyclic compounds; Hexosamines; Macrocyclic compounds; Organometallic compounds; Sugar alcohols
- Mechanism of Action Magnetic resonance imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration CNS disorders; Vascular disorders